See also this year's filing and all EDGAR filings for this company.
PDF Report 0001235007_2018_Endocyte_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001235007, Endocyte INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,572,803 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,182,399 |
| 3 | remainder_Assets | 7,067 |
| 4 | LiabilitiesCurrent | 4,546,180 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 731,944 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,014,514 |
| 9 | ResearchAndDevelopmentExpense | 41,016,838 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,497,760 |
| 13 | remainder_ComprehensiveNetIncome | -2,549 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 100,762,269 |
| 1 | Liabilities | 5,278,124 |
| 2 | Expenses | 55,031,352 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 95,484,145 |
| 5 | NetIncome | -53,533,592 |
| 6 | ComprehensiveNetIncome | -53,534,866 |
| 7 | BaseVar | 81,286,027 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.92 |
| 9 | EconomicCapitalRatio | 3.63 |